. 2023 Feb 14;30(17):49779–49797. doi: 10.1007/s11356-023-25661-x

Table 3.

Changes in alanine transaminase activity (U/I), alkaline phosphatase (U/I), creatinine level (U/I), and serum progesterone level (ng/Ml) of pregnant Wister albino rats after treating with low and high doses of MSG at different days of gestation

	Time (days)	Control	Treated
	Time (days)	Control	Low dose	High dose
Alanine transaminase activity (U/I)	14th day of gestation	22.33 ± 1.84^c	32.3 ± 3.63^bc	42.36 ± 9.87^b
Alanine transaminase activity (U/I)	19th day of gestation	23.06 ± 2.19^c	50.18 ± 10.93^ab	60.97 ± 8.45^a
Alkaline phosphatase (U/I)	14th day of gestation	195.01 ± 15.96^c	200.0 ± 12.41^c	400.66 ± 42.87^a
Alkaline phosphatase (U/I)	19th day of gestation	148.93 ± 7.04^c	203.78 ± 6.78^c	306.0 ± 20.94^b
Creatinine level (U/I)	14th day of gestation	0.8 ± 0.23^d	1.83 ± 0.10b^c	1.57 ± 0.12^ab
Creatinine level (U/I)	19th day of gestation	1.09 ± 0.25^cd	1.91 ± 0.17^a	1.78 ± 0.16^ab
Serum progesterone level (ng/Ml)	7th day of gestation	54.0 ± 2.30^a	40.0 ± 1.70^b	31.0 ± 3.50^c
	14th day of gestation	62.5 ± 3.00^a	38.2 ± 0.80^b	46.5 ± 1.50^c
	19th day of gestation	31.0 ± 3.50^a	34.5 ± 1.50^a	70.25 ± 2.00^c

Data represent the mean value ± S.E. from10 rat/group. Mean values with different superscript letters within the same row are significantly different at P ≤ 0.05 using ANOVA followed by the Duncan’s multiple comparison test